A human monoclonal antibody blocking SARS-CoV-2 infection

The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunyan, Li, Wentao, Drabek, Dubravka, Okba, Nisreen M. A., van Haperen, Rien, Osterhaus, Albert D. M. E., van Kuppeveld, Frank J. M., Haagmans, Bart L., Grosveld, Frank, Bosch, Berend-Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198537/
https://www.ncbi.nlm.nih.gov/pubmed/32366817
http://dx.doi.org/10.1038/s41467-020-16256-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198537/
https://www.ncbi.nlm.nih.gov/pubmed/32366817
http://dx.doi.org/10.1038/s41467-020-16256-y

Ejemplares similares